Literature DB >> 17950969

Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?

Bankole A Johnson1, Martin A Javors, John D Roache, Chamindi Seneviratne, Susan E Bergeson, Nassima Ait-Daoud, Michael A Dawes, Jennie Z Ma.   

Abstract

Serotonin transporter (5-HTT) activity is greater in carriers of the long (L) vs. short (S) alleles of the 5-HTT-linked polymorphic region (5'-HTTLPR) among healthy control subjects but not alcohol-dependent adults. In 198 alcoholics, we determined the relationship between current or lifetime drinking and platelet 5-HTT function and density among allelic variants of the 5'-HTTLPR. SS subjects were younger than L-carriers (LL and LS) (p<0.0085) and had fewer years of lifetime drinking. For L-carriers, the mean of Bmax for paroxetine binding, but not Vmax for serotonin (5-HT) uptake, was lower than that for SS subjects (p<0.05). More L-carriers than their SS counterparts had Vmax for 5-HT uptake below 200 nmol/10(7) platelets-min (p<0.05) and Bmax for paroxetine binding below 600 nmol/mg protein (p<0.06). Current drinking (drinks per day during the past 14 days) correlated positively with Km and Vmax of platelet 5-HT uptake (p<0.05) and negatively with Bmax, but not Kd, of paroxetine binding (p<0.05) for L-carriers alone. Years of lifetime drinking correlated negatively with Km and Vmax of platelet 5-HT uptake (p<0.05) and B(max), but not Kd, of paroxetine binding (p<0.05) for L-carriers alone. Among L-carriers alone, there were higher levels of platelet 5-HT uptake and lower levels of platelet paroxetine binding with increased drinking, and more lifetime drinking was associated with modestly lower levels of 5-HT uptake and paroxetine binding. Thus, 5-HTT expression varies with current and lifetime drinking in L-carriers alone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950969      PMCID: PMC2270792          DOI: 10.1016/j.pnpbp.2007.07.030

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  42 in total

Review 1.  The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.

Authors:  C A Naranjo; D M Knoke
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

2.  The role of anxiety in predicting drinking behaviour.

Authors:  Tracy B Sloan; John D Roache; Bankole A Johnson
Journal:  Alcohol Alcohol       Date:  2003 Jul-Aug       Impact factor: 2.826

3.  Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.

Authors:  Jerzy Samochowiec; Jolanta Kucharska-Mazur; Anna Grzywacz; Marcin Jabłoński; Hans Rommelspacher; Agnieszka Samochowiec; Mariusz Sznabowicz; Jan Horodnicki; Leszek Sagan; Justyna Pełka-Wysiecka
Journal:  Neurosci Lett       Date:  2006-10-31       Impact factor: 3.046

4.  Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.

Authors:  Martin A Javors; Chamindi Seneviratne; John D Roache; Nassima Ait-Daoud; Susan E Bergeson; M Consuelo Walss-Bass; Fatema Z Akhtar; Bankole A Johnson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-11-04       Impact factor: 5.067

5.  Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.

Authors:  B D Greenberg; T J Tolliver; S J Huang; Q Li; D Bengel; D L Murphy
Journal:  Am J Med Genet       Date:  1999-02-05

Review 6.  Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents.

Authors:  W J McBride; T K Li
Journal:  Crit Rev Neurobiol       Date:  1998

7.  Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women.

Authors:  Aryeh I Herman; Kristi M Kaiss; Rui Ma; John W Philbeck; Asfar Hasan; Humza Dasti; Paolo B DePetrillo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-02-05       Impact factor: 3.568

8.  Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine.

Authors:  Martin A. Javors; John P. Houston; Janet L. Tekell; Stephen K. Brannan; Alan Frazer
Journal:  Int J Neuropsychopharmacol       Date:  2000-09       Impact factor: 5.176

9.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Authors:  S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

10.  The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings.

Authors:  M J Bohn; T F Babor; H R Kranzler
Journal:  J Stud Alcohol       Date:  1995-07
View more
  21 in total

Review 1.  Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy.

Authors:  Miles D Thompson; George A Kenna
Journal:  Alcohol Alcohol       Date:  2015-08-26       Impact factor: 2.826

2.  Can serotonin transporter genotype predict craving in alcoholism?

Authors:  Nassima Ait-Daoud; John D Roache; Michael A Dawes; Lei Liu; Xin-Qun Wang; Martin A Javors; Chamindi Seneviratne; Bankole A Johnson
Journal:  Alcohol Clin Exp Res       Date:  2009-05-04       Impact factor: 3.455

3.  Self-assembling nanoparticles for intra-articular delivery of anti-inflammatory proteins.

Authors:  Rachel E Whitmire; D Scott Wilson; Ankur Singh; Marc E Levenston; Niren Murthy; Andrés J García
Journal:  Biomaterials       Date:  2012-07-17       Impact factor: 12.479

Review 4.  Role of the serotonergic system in alcohol dependence: from animal models to clinics.

Authors:  Youssef Sari; Verity R Johnson; Jason M Weedman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

5.  Commentary: Targeting NMDA Receptor and Serotonin Transporter for the Treatment of Comorbid Alcohol Dependence and Depression.

Authors:  Youssef Sari
Journal:  Alcohol Clin Exp Res       Date:  2017-01-19       Impact factor: 3.455

6.  The serotonin transporter gene and startle response during nicotine deprivation.

Authors:  Jennifer A Minnix; Jason D Robinson; Cho Y Lam; Brian L Carter; Jennifer E Foreman; David J Vandenbergh; Gail E Tomlinson; David W Wetter; Paul M Cinciripini
Journal:  Biol Psychol       Date:  2010-10-01       Impact factor: 3.251

7.  Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.

Authors:  George A Kenna; William H Zywiak; Robert M Swift; John E McGeary; James S Clifford; Jessica R Shoaff; Cynthia Vuittonet; Samuel Fricchione; Michael Brickley; Kayla Beaucage; Carolina L Haass-Koffler; Lorenzo Leggio
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

8.  Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism.

Authors:  John D Roache; Yanmei Wang; Nassima Ait-Daoud; Bankole A Johnson
Journal:  Alcohol Clin Exp Res       Date:  2008-06-28       Impact factor: 3.455

9.  Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter.

Authors:  Michael A Dawes; John D Roache; Martin A Javors; Susan E Bergeson; Dawn M Richard; Charles W Mathias; Nassima Ait-Daoud; Donald M Dougherty; Bankole A Johnson
Journal:  J Stud Alcohol Drugs       Date:  2009-11       Impact factor: 2.582

10.  Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensity.

Authors:  Chamindi Seneviratne; Weihua Huang; Nassima Ait-Daoud; Ming D Li; Bankole A Johnson
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.